These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21789792)

  • 1. c-JUN prevents methylation of p16(INK4a) (and Cdk6): the villain turned bodyguard.
    Kollmann K; Heller G; Sexl V
    Oncotarget; 2011 May; 2(5):422-7. PubMed ID: 21789792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-JUN promotes BCR-ABL-induced lymphoid leukemia by inhibiting methylation of the 5' region of Cdk6.
    Kollmann K; Heller G; Ott RG; Scheicher R; Zebedin-Brandl E; Schneckenleithner C; Simma O; Warsch W; Eckelhart E; Hoelbl A; Bilban M; Zöchbauer-Müller S; Malumbres M; Sexl V
    Blood; 2011 Apr; 117(15):4065-75. PubMed ID: 21300982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumor suppressor p16(INK4a) prevents cell transformation through inhibition of c-Jun phosphorylation and AP-1 activity.
    Choi BY; Choi HS; Ko K; Cho YY; Zhu F; Kang BS; Ermakova SP; Ma WY; Bode AM; Dong Z
    Nat Struct Mol Biol; 2005 Aug; 12(8):699-707. PubMed ID: 16007099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16INK4a suppresses BRCA1-deficient mammary tumorigenesis.
    Scott A; Bai F; Chan HL; Liu S; Ma J; Slingerland JM; Robbins DJ; Capobianco AJ; Pei XH
    Oncotarget; 2016 Dec; 7(51):84496-84507. PubMed ID: 27811360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
    Wen-Sheng W
    Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term arsenic exposure induces histone H3 Lys9 dimethylation without altering DNA methylation in the promoter region of p16(INK4a) and down-regulates its expression in the liver of mice.
    Suzuki T; Nohara K
    J Appl Toxicol; 2013 Sep; 33(9):951-8. PubMed ID: 22733434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H3K27 trimethylation is an early epigenetic event of p16INK4a silencing for regaining tumorigenesis in fusion reprogrammed hepatoma cells.
    Yao JY; Zhang L; Zhang X; He ZY; Ma Y; Hui LJ; Wang X; Hu YP
    J Biol Chem; 2010 Jun; 285(24):18828-37. PubMed ID: 20382980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CREG1 enhances p16(INK4a) -induced cellular senescence.
    Moolmuang B; Tainsky MA
    Cell Cycle; 2011 Feb; 10(3):518-30. PubMed ID: 21263217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of the Dlc1 gene cooperates with downregulation of p15INK4b and p16Ink4a, leading to neoplastic transformation and poor prognosis in human cancer.
    Qian X; Durkin ME; Wang D; Tripathi BK; Olson L; Yang XY; Vass WC; Popescu NC; Lowy DR
    Cancer Res; 2012 Nov; 72(22):5900-11. PubMed ID: 23010077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JunB is a gatekeeper for B-lymphoid leukemia.
    Ott RG; Simma O; Kollmann K; Weisz E; Zebedin EM; Schorpp-Kistner M; Heller G; Zöchbauer S; Wagner EF; Freissmuth M; Sexl V
    Oncogene; 2007 Jul; 26(33):4863-71. PubMed ID: 17297445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The methylation locus and frequency pattern on p16 INK4a gene promoter CpG in epidermis of patients with psoriasis].
    Chen M; Cui PG; Yao X; Cao YH; Gong JQ; Li AS; Chen ZQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):674-6. PubMed ID: 18067081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p16(INK4a) and p53 deficiency cooperate in tumorigenesis.
    Sharpless NE; Alson S; Chan S; Silver DP; Castrillon DH; DePinho RA
    Cancer Res; 2002 May; 62(10):2761-5. PubMed ID: 12019151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma.
    Matsuda Y
    World J Gastroenterol; 2008 Mar; 14(11):1734-40. PubMed ID: 18350604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor suppressor p16INK4A is necessary for survival of cervical carcinoma cell lines.
    McLaughlin-Drubin ME; Park D; Munger K
    Proc Natl Acad Sci U S A; 2013 Oct; 110(40):16175-80. PubMed ID: 24046371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
    Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
    Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H3K9me-enhanced DNA hypermethylation of the p16INK4a gene: an epigenetic signature for spontaneous transformation of rat mesenchymal stem cells.
    Zheng Y; He L; Wan Y; Song J
    Stem Cells Dev; 2013 Jan; 22(2):256-67. PubMed ID: 22873822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequency of p16(INK4A) promoter methylation in NRAS-mutated cutaneous melanoma.
    Jonsson A; Tuominen R; Grafström E; Hansson J; Egyhazi S
    J Invest Dermatol; 2010 Dec; 130(12):2809-17. PubMed ID: 20703244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues.
    Ramsey MR; Krishnamurthy J; Pei XH; Torrice C; Lin W; Carrasco DR; Ligon KL; Xiong Y; Sharpless NE
    Cancer Res; 2007 May; 67(10):4732-41. PubMed ID: 17510401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA (cytosine-5)-methyltransferase 1 as a mediator of mutant p53-determined p16(ink4A) down-regulation.
    Guo Z; Tsai MH; Shiao YH; Chen LH; Wei ML; Lv X; Gius D; Little JB; Mitchell JB; Chuang EY
    J Biomed Sci; 2008 Mar; 15(2):163-8. PubMed ID: 18038118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing of the p16(INK4a) tumor suppressor is associated with loss of CTCF binding and a chromatin boundary.
    Witcher M; Emerson BM
    Mol Cell; 2009 May; 34(3):271-84. PubMed ID: 19450526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.